The ProtekDuo dual-lumen cannula for temporary acute mechanical circulatory support in right heart failure: A systematic review
- 3 January 2023
- journal article
- review article
- Published by SAGE Publications in Perfusion
- Vol. 38 (1_suppl) , 59-67
Abstract
Introduction: Acute right ventricular failure (aRVF) is associated with high mortality and morbidity. Mechanical circulatory support (MCS) may be considered as an advanced treatment option. The ProtekDuo is a cannula that can be used to provide acute right ventricular support as part of a temporary percutaneous (tp) right ventricular assist device (RVAD) system. The primary objective of this systematic review is to describe patient survival and complications when the ProtekDuo cannula was used as part of an tpRVAD system. Methods: MEDLINE, Embase, and Scopus were searched from database inception to August 26, 2022. Reference sections of studies were reviewed to screen for database omissions. Results: Seven studies with 127 patients were eligible for inclusion. The studies included patients with aRVF from a variety of causes. Mean duration of support was between 10 and 58 days in five studies. Patient survival to discharge was between 60% and 85.2% in two studies. Four authors reported 30-day survival between 60% and 85.2%. Devicerelated and non-device related complications were low. Conclusions: Patients treated with RVAD using the ProtekDuo cannula have comparable survival rates and complications to other tpRVAD systems. Several advantages exist compared to other RVAD systems.Keywords
This publication has 22 references indexed in Scilit:
- Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP deviceThe Journal of Heart and Lung Transplantation, 2018
- Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist DeviceASAIO Journal, 2018
- Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart AssociationCirculation, 2018
- Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation†European Journal of Cardio-Thoracic Surgery, 2017
- Mechanical Circulatory Support Devices for Acute Right Ventricular FailureCirculation, 2017
- Minimally invasive approach for percutaneous CentriMag right ventricular assist device support using a single PROTEKDuo CannulaJournal of Cardiothoracic Surgery, 2016
- Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of CardiologyEuropean Journal of Heart Failure, 2016
- A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapyThe Journal of Heart and Lung Transplantation, 2015
- Short-term mechanical circulatory support for recovery from acute right ventricular failure: Clinical outcomesThe Journal of Heart and Lung Transplantation, 2014
- Hemolysis in left ventricular assist device: A retrospective analysis of outcomesThe Journal of Heart and Lung Transplantation, 2014